Market Intelligence

The number one source for bespoke market intelligence reports for the medical and healthcare sector, gathered and analyzed by our team of experts.

  • Medilink UK strongly advocates that businesses should have a central role in the industrial strategy and any associated processes for innovation, given they invest heavily in research and development, have important applicable skill sets, and have unique specialist market knowledge. Medilink UK believes that the core principles in its formal response to the Accelerated Access Review (AAR) are equally applicable within this response to the Industrial Strategy Green Paper.
  • At a time when the NHS is planning for 2016/17 and beyond, this briefing considers some of the key publications and policy announcements that have come out in the wake of the 2015 Spending Review and offers a commentary on what they might mean for the future landscape of the NHS.
  • The NHS in England is facing growing financial and service pressures at a time of rising demand. This paper proposes a new approach to tackling these challenges. It argues that NHS organisations need to move away from a ‘fortress mentality’ whereby they act to secure their own individual interests and future, and instead establish place-based ‘systems of care’ in which they collaborate with other NHS organisations and services to address the challenges and improve the health of the populations they serve.
  • This discussion paper reflects the work in progress from one third of STP areas, as captured in July and August 2016. It shows that the scale of the STP process is large and ambitious, and the speed with which plans are being pulled together is astonishing. So far, the plans are not sufficient to close the funding gap, but, if implemented well and combined with high-quality local efficiency improvement, they would go some way to doing so and would demonstrate the capability of the NHS and social care system to deliver. This paper points to some important trends, ideas to be explored and issues that need to be resolved in order to ensure success.
  • This guideline covers the recognition, diagnosis and early management of sepsis for all populations. The guideline committee identified that the key issues to be included were: recognition and early assessment, diagnostic and prognostic value of blood markers for sepsis, initial treatment, escalating care, identifying the source of infection, early monitoring, information and support for patients and carers, and training and education.